Cade, Telix Group Chief Medical Officer, said, “Telix will feature in four presentations at this year’s ASCO GU, which showcase the depth and differentiation of our therapeutic urologic pipeline, ...

Dr. Levitt will present Adolore's innovative CA8* chronic pain therapeutic (*carbonic anhydrase-like analgesic peptides, CA8 variants) and its cutting-edge technology using disease-free ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator.